
H. Eric Cannon, PharmD, FAMCP
Advertisement
Articles by H. Eric Cannon, PharmD, FAMCP


Stakeholders, including national and regional managed care decision makers and providers, met to discuss the clinical background, health economics, and management strategies for pulmonary arterial hypertension (PAH) at a roundtable meeting on December 10, 2016, in Dallas, Texas.
Advertisement
Latest Updated Articles
Considerations for Optimal Management of Patients With Pulmonary Arterial Hypertension: A Multi-Stakeholder Roundtable DiscussionPublished: May 19th 2017 | Updated:
The Economic Impact of Peanut AllergiesPublished: October 19th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Vutrisiran Improves Survival, Cardiovascular Outcomes Across Age Groups in ATTR-CM
2
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
3
Most Patients With MCL in Study of Pirtobrutinib Show Stable or Improved Physical Symptoms, QOL
4
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
5



